XML 19 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 28, 2024
Sep. 30, 2023
Sep. 28, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Net revenues $ 81,006 $ 75,312 $ 249,794 $ 269,697
Cost of goods sold 66,698 82,566 218,101 268,493
Gross profit (loss) 14,308 (7,254) 31,693 1,204
Research and development expenses 6,133 9,118 21,478 30,323
Selling, general and administrative expenses 39,084 53,252 128,529 152,607
Restructuring expenses 0 (4) 0 (631)
Total operating expenses 45,217 62,366 150,007 182,299
Loss from operations (30,909) (69,620) (118,314) (181,095)
Other income (expense), net:        
Interest expense (1,028) (989) (3,072) (2,967)
Other, net 5,405 243 6,005 4,897
Total other income (expense), net 4,377 (746) 2,933 1,930
Loss before taxes (26,532) (70,366) (115,381) (179,165)
Income tax expense (benefit) 6 0 (26) 5
Equity in losses of unconsolidated joint venture 38 126 61 3,864
Net loss $ (26,576) $ (70,492) $ (115,416) $ (183,034)
Net loss per share available to common stockholders—basic (in dollars per share) $ (0.41) $ (1.09) $ (1.78) $ (2.85)
Net loss per share available to common stockholders—diluted (in dollars per share) $ (0.41) $ (1.09) $ (1.78) $ (2.85)
Weighted average common shares outstanding—basic (in shares) 65,060,729 64,398,448 64,880,008 64,210,809
Weighted average common shares outstanding—diluted (in shares) 65,060,729 64,398,448 64,880,008 64,210,809